Reprogramming of T cells from human peripheral blood

Yuin Han Loh; Odelya Hartung; Hu Li; Chunguang Guo; Julie M. Sahalie; Philip D. Manos; Achia Urbach; Garrett C. Heffner; Marica Grskovic; Francois Vigneault; M. William Lensch; In Hyun Park; Suneet Agarwal; George M. Church; James J. Collins; Stefan Irion; George Q. Daley

doi:10.1016/j.stem.2010.06.004

Reprogramming of T cells from human peripheral blood

Yuin Han Loh, Odelya Hartung, Hu Li, Chunguang Guo, Julie M. Sahalie, Philip D. Manos, Achia Urbach, Garrett C. Heffner, Marica Grskovic, Francois Vigneault, M. William Lensch, In Hyun Park, Suneet Agarwal, George M. Church, James J. Collins, Stefan Irion, George Q. Daley

Research output: Contribution to journal › Article › peer-review

262 Scopus citations

Original language	English
Pages (from-to)	15-19
Number of pages	5
Journal	Cell Stem Cell
Volume	7
Issue number	1
DOIs	https://doi.org/10.1016/j.stem.2010.06.004
State	Published - 2 Jul 2010
Externally published	Yes

Bibliographical note

Funding Information:
This research was funded by grants from the National Institutes of Health (NIH) and the Howard Hughes Medical Institute to G.Q.D. J.J.C. is supported by SysCODE (Systems-based Consortium for Organ Design & Engineering), NIH grant # RL1DE019021. Y.-H.L. is supported by the overseas fellowship from Agency of Science, Technology, and Research (A ∗ Star) and the Institute of Medical Biology, Singapore. We are grateful to Ann M. Mullally, Anupama Narla, Benjamin L. Ebert, Lars U.W. Müller, Axel Schambach, and Stelios Andreadis for technical assistances. We acknowledge Sabine Loewer for helpful discussions and critical comments on the manuscript. G.Q.D. is a member of the Scientific Advisory Board of iPierian, Inc. M.G. and S.I. are employed by iPierian, Inc., a biotechnology company using iPSCs for drug discovery.

Funding

This research was funded by grants from the National Institutes of Health (NIH) and the Howard Hughes Medical Institute to G.Q.D. J.J.C. is supported by SysCODE (Systems-based Consortium for Organ Design & Engineering), NIH grant # RL1DE019021. Y.-H.L. is supported by the overseas fellowship from Agency of Science, Technology, and Research (A ∗ Star) and the Institute of Medical Biology, Singapore. We are grateful to Ann M. Mullally, Anupama Narla, Benjamin L. Ebert, Lars U.W. Müller, Axel Schambach, and Stelios Andreadis for technical assistances. We acknowledge Sabine Loewer for helpful discussions and critical comments on the manuscript. G.Q.D. is a member of the Scientific Advisory Board of iPierian, Inc. M.G. and S.I. are employed by iPierian, Inc., a biotechnology company using iPSCs for drug discovery.

Funders	Funder number
A ∗ Star
National Institutes of Health
Howard Hughes Medical Institute
National Institute of Dental and Craniofacial Research	RL1DE019021
Agency for Science, Technology and Research

Access to Document

10.1016/j.stem.2010.06.004

Cite this

@article{f4d73a2a53bf42e58554f9a013a7aef7,

title = "Reprogramming of T cells from human peripheral blood",

author = "Loh, {Yuin Han} and Odelya Hartung and Hu Li and Chunguang Guo and Sahalie, {Julie M.} and Manos, {Philip D.} and Achia Urbach and Heffner, {Garrett C.} and Marica Grskovic and Francois Vigneault and {William Lensch}, M. and Park, {In Hyun} and Suneet Agarwal and Church, {George M.} and Collins, {James J.} and Stefan Irion and Daley, {George Q.}",

note = "Funding Information: This research was funded by grants from the National Institutes of Health (NIH) and the Howard Hughes Medical Institute to G.Q.D. J.J.C. is supported by SysCODE (Systems-based Consortium for Organ Design & Engineering), NIH grant # RL1DE019021. Y.-H.L. is supported by the overseas fellowship from Agency of Science, Technology, and Research (A ∗ Star) and the Institute of Medical Biology, Singapore. We are grateful to Ann M. Mullally, Anupama Narla, Benjamin L. Ebert, Lars U.W. M{\"u}ller, Axel Schambach, and Stelios Andreadis for technical assistances. We acknowledge Sabine Loewer for helpful discussions and critical comments on the manuscript. G.Q.D. is a member of the Scientific Advisory Board of iPierian, Inc. M.G. and S.I. are employed by iPierian, Inc., a biotechnology company using iPSCs for drug discovery. ",

year = "2010",

month = jul,

day = "2",

doi = "10.1016/j.stem.2010.06.004",

language = "אנגלית",

volume = "7",

pages = "15--19",

journal = "Cell Stem Cell",

issn = "1934-5909",

publisher = "Cell Press",

number = "1",

}

TY - JOUR

T1 - Reprogramming of T cells from human peripheral blood

AU - Loh, Yuin Han

AU - Hartung, Odelya

AU - Li, Hu

AU - Guo, Chunguang

AU - Sahalie, Julie M.

AU - Manos, Philip D.

AU - Urbach, Achia

AU - Heffner, Garrett C.

AU - Grskovic, Marica

AU - Vigneault, Francois

AU - William Lensch, M.

AU - Park, In Hyun

AU - Agarwal, Suneet

AU - Church, George M.

AU - Collins, James J.

AU - Irion, Stefan

AU - Daley, George Q.

N1 - Funding Information: This research was funded by grants from the National Institutes of Health (NIH) and the Howard Hughes Medical Institute to G.Q.D. J.J.C. is supported by SysCODE (Systems-based Consortium for Organ Design & Engineering), NIH grant # RL1DE019021. Y.-H.L. is supported by the overseas fellowship from Agency of Science, Technology, and Research (A ∗ Star) and the Institute of Medical Biology, Singapore. We are grateful to Ann M. Mullally, Anupama Narla, Benjamin L. Ebert, Lars U.W. Müller, Axel Schambach, and Stelios Andreadis for technical assistances. We acknowledge Sabine Loewer for helpful discussions and critical comments on the manuscript. G.Q.D. is a member of the Scientific Advisory Board of iPierian, Inc. M.G. and S.I. are employed by iPierian, Inc., a biotechnology company using iPSCs for drug discovery.

PY - 2010/7/2

Y1 - 2010/7/2

UR - http://www.scopus.com/inward/record.url?scp=77957658573&partnerID=8YFLogxK

U2 - 10.1016/j.stem.2010.06.004

DO - 10.1016/j.stem.2010.06.004

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 20621044

AN - SCOPUS:77957658573

SN - 1934-5909

VL - 7

SP - 15

EP - 19

JO - Cell Stem Cell

JF - Cell Stem Cell

IS - 1

ER -

Reprogramming of T cells from human peripheral blood

Bibliographical note

Funding

Access to Document

Other files and links

Cite this